000			01334 a2200349 4500
005			20250516040606.0
264		0	_c20111201
008			201112s 0 0 eng d
022			_a1872-8278
024	7		_a10.1016/j.mito.2011.05.002 _2doi
040			_aNLM _beng _cNLM
100	1		_aStacpoole, Peter W
245	0	0	_aWhy are there no proven therapies for genetic mitochondrial diseases? _h[electronic resource]
260			_bMitochondrion _cSep 2011
300			_a679-85 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAcidosis, Lactic _xcongenital
650	0	4	_aAnimals
650	0	4	_aDichloroacetic Acid _xtherapeutic use
650	0	4	_aFinancing, Government
650	0	4	_aHumans
650	0	4	_aMELAS Syndrome _xdrug therapy
650	0	4	_aMitochondrial Diseases _xdrug therapy
650	0	4	_aNeglected Diseases _xdrug therapy
650	0	4	_aRandomized Controlled Trials as Topic _xeconomics
650	0	4	_aRare Diseases _xdrug therapy
650	0	4	_aSocieties, Medical _xeconomics
650	0	4	_aUbiquinone _xanalogs & derivatives
650	0	4	_aUnited States
773	0		_tMitochondrion _gvol. 11 _gno. 5 _gp. 679-85
856	4	0	_uhttps://doi.org/10.1016/j.mito.2011.05.002 _zAvailable from publisher's website
999			_c20867304 _d20867304